Keyphrases
Statin-associated muscle Symptoms
100%
Homozygous Familial Hypercholesterolemia (HoFH)
100%
Hypercholesterolemia
80%
Low-density Lipoprotein Cholesterol (LDL-C)
40%
Statin Therapy
40%
Clinical Features
40%
Monoclonal Antibody
40%
Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9)
40%
Statins
20%
Dyslipidemia
20%
Life-threatening
20%
Safety Profile
20%
Elevated Creatine Kinase
20%
Lipid-lowering Agents
20%
Muscle Toxicity
20%
Tolerability
20%
Myalgia
20%
Rhabdomyolysis
20%
High-density Lipoprotein Cholesterol (HDL-C)
20%
User Experience
20%
Life Expectancy
20%
Cardiovascular Risk
20%
Feature Study
20%
Evolocumab
20%
Positive Family History
20%
Alirocumab
20%
Clinical Genetics
20%
Novel Therapeutic Targets
20%
Genetic Studies
20%
Coronary Artery Disease Severity
20%
Heritable Disorders
20%
LDL Receptor
20%
Pharmacology, Toxicology and Pharmaceutical Science
Statin (Protein)
100%
Familial Hypercholesterolemia
100%
Hypercholesterolemia
80%
Monoclonal Antibody
40%
Clinical Feature
40%
Proprotein Convertase 9
40%
Disease
20%
Antilipemic Agent
20%
Dyslipidemia
20%
Low Density Lipoprotein Cholesterol
20%
Creatine Kinase
20%
Tolerability
20%
Rhabdomyolysis
20%
Myalgia
20%
Life Expectancy
20%
Coronary Artery Disease
20%
Alirocumab
20%
Evolocumab
20%
Low Density Lipoprotein Receptor
20%
High Density Lipoprotein
20%
Cardiovascular Disease
20%